BroMocriptine-13C-d3

Product Name: BroMocriptine-13C-d3
Chemical Name: BroMocriptine-13C-d3
Synonyms: BroMocriptine-13C-d3
CBNumber: CB42673660
Molecular Formula: C32H37BrD3N5O5
Formula Weight: 658.621985334
MOL File: Mol file

More

Less

BroMocriptine-13C-d3 Property

solubility: Chloroform: soluble

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Cayman Chemical

Product number: 26669
Product name: Bromocriptine-13C-d3
Packaging: 500μg
Price: $413
Updated: 2024/03/01

Cayman Chemical

Product number: 26669
Product name: Bromocriptine-13C-d3
Packaging: 1mg
Price: $783
Updated: 2024/03/01

American Custom Chemicals Corporation

Product number: RDL0006691
Product name: BROMOCRIPTINE-13C-D3
Purity: 95.00%
Packaging: 5MG
Price: $500.93
Updated: 2021/12/16

More

Less

BroMocriptine-13C-d3 Chemical Properties,Usage,Production

Description

Bromocriptine-13C-d3 is intended for use as an internal standard for the quantification of bromocriptine (Item No. 14598) by GC- or LC-MS. Bromocriptine is a dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM for dopamine D1, D2, D3, D4, and D5 receptors, respectively).1 It also binds to the serotonin (5-HT) receptor subtypes 5-HT1A and 5-HT1D (Kis = 12.9 and 10.7 nM, respectively), as well as α1-adrenergic receptors (Kis = 1.12-4.17 nM).1,2 Bromocriptine (5 mg/kg) restores locomotor activity, without inducing dyskinesia, in a macaque model of Parkinson’s disease induced by MPTP.3 Formulations containing bromocriptine have been used in the treatment of Parkinson's disease, hyperprolactinemia-associated dysfunctions, and acromegaly.WARNING This product is not for human or veterinary use.

References

[1] MSC TROND KVERNMO PhD E B PhD Sebastian Härtter. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists[J]. Clinical therapeutics, 2006, 28 8: Pages 1065-1078. DOI: 10.1016/j.clinthera.2006.08.004
[2] MARK J MILLAN. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.[J]. Journal of Pharmacology and Experimental Therapeutics, 2002, 303 2: 791-804. DOI: 10.1124/jpet.102.039867
[3] C. ROUILLARD T. D P P J Bédard. Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393[J]. European journal of pharmacology, 1990, 185 2: Pages 209-215. DOI: 10.1016/0014-2999(90)90642-j

BroMocriptine-13C-d3 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

BroMocriptine-13C-d3 Suppliers

CHINA 7 United States 2 Global 9

ChemeGen(Shanghai) Biotechnology Co.,Ltd.

Tel: 18818260767
Fax: QQ 3610331285
Email: sales@chemegen.com
Country: China
ProdList: 11218
Advantage: 58

TLC Pharmaceutical Standards Ltd.

Tel: 18012923235; 18012923235
Email: chinasales04@tlcstandards.com.cn
Country: China
ProdList: 7974
Advantage: 58

BePure (Beijing) Biotechnology Co.

Tel: 58896805
Email: 7993601name@qq.com
Country: CHINA
ProdList: 6620
Advantage: 58

Cayman Chemical Company

Tel: 800-364-9897
Email: sales@caymanchem.com
Country: China
ProdList: 6838
Advantage: 58

TargetMol Chemicals Inc.

Tel: +17819995354
Email: marketing@targetmol.com
Country: United States
ProdList: 19962
Advantage: 58

BroMocriptine-13C-d3Related Search:

(8S)-2-BroMo α-Ergocryptine Bromocriptine Impurity 2 ALPHA-ERGOCRYPTINE 5'alpha(S)-sec-butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (2'β,5'α,8α)- (9CI) BroMocriptine IMpurity G Bromocriptine Bromocriptine mesylate BroMocriptine IMpurity F Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- Bromocriptine Impurity A (Mixture of Diastereomers) BroMocriptine IMpurity E

BroMocriptine-13C-d3